D3 Bio is a biotechnology company that develops medicines for oncology and immunology patients. It creates precision medicines that match therapies to the disease biomarkers of individual patients. The company aims to help convert life-threatening cancers into manageable chronic conditions.
D3 Bio total Funding
D3 Bio latest funding size
Time since last funding
|9 months ago|
D3 Bio investors
|Matrix Partners China, Boyu Capital, WuXi AppTec, Temasek, Sequoia Capital China|
When was D3 Bio founded?
D3 Bio was founded in 2014.
Who are D3 Bio key executives?
D3 Bio's key executives are George Chen.
Who are D3 Bio competitors?
Competitors of D3 Bio include Exelixis, CureVac and Nektar Therapeutics.
Where is D3 Bio headquarters?
D3 Bio headquarters is located at Shang'ai, Jinxian County, Shangai.
Where are D3 Bio offices?
D3 Bio has an office in Shangai.
How many offices does D3 Bio have?
D3 Bio has 1 office.
Receive alerts for 300+ data fields across thousands of companies